CNBC's Bob Pisani looks ahead at what’s moving markets this morning including drugstores.
CNBC's Meg Tirrell reports on drugmaker Eli Lilly responding to tweets from Sen. Bernie Sanders over the price of its Humalog insulin treatment.
Here's why the same old lobbying and crony networks won't help Big Pharma protect its pricing schemes, says Jake Novak.
CNBC's Bertha Coombs reports on the moves in McKesson after its quarterly earnings release.
CNBC's Meg Tirrell speaks to Bristol-Myers CEO Giovanni Caforio about his company's earnings and outlook, August drug trial results, the election and potential M&A.
Opium production in Afghanistan has increased 43 percent in the past year.
CNBC's Meg Tirrell reports the latest on Alkermes' latest depression drug trial.
Jim Cramer is seeing signals that money managers are preparing for a Democratic landslide. He outlines what it could mean for stocks.
Jefferies downgrades Pfizer to hold from buy.
Researchers are working on opioids with all the painkilling power of current drugs but with less risk of addiction or overdose.
Jim Cramer says uncertainty surrounding a Democratic win for the White House puts drug stocks in the danger zone.
The Philippine President's off-the-cuff comments seem like rhetoric but he's made good on promises to target crime and corruption, says Oxford Economics' Oliver Salmon.
Shares of Bristol-Myers Squibb fell 10 percent, after the Opdivo trial result did not meet expectations.
CNBC's Meg Tirrell reports on why billions are at stake for Bristol-Myers and Merck. The “Fast Money” traders weigh in.
CNBC's Julia Boorstin reports the latest on Facebook's Marketplace as within hour of launch, illegal sales were taking place on the platform.
Duterte says he would 'be happy' to exterminate three million drug users and peddlers in the country.
Over 3,100 people have been killed since Duterte came to power on a pledge to end drugs and corruption in the country.
A house exploded Tuesday morning in the Bronx killing a FDNY battalion chief and injuring at least 12 people, according to a NBC New York report.
Former FDA Deputy Commissioner Scott Gottlieb, M.D. weighs in on Mylan's pricing outrage and what's really driving drug price hikes.
Philippine President Rodrigo Duterte invited UN Secretary-General Ban Ki-moon and the European Union to investigate his anti-drugs crackdown.